Pengpeng Xu
- Molecular Biology
- Oncology top 10%
- Pathology and Forensic Medicine top 5%
- Immunology
- Cancer Research top 10%
- Co-authors
- Shu ChengWeili ZhaoLi WangDi FuJinyan HuangYing FangHongmei YiMengyuan Ji
- Topics
- Lymphoma Diagnosis and Treatment (47 papers)CAR-T cell therapy research (21 papers)Chronic Lymphocytic Leukemia Research (14 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Pengpeng Xu
73 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Biology 459
- Oncology 396
- Pathology and Forensic Medicine 387
- Immunology 209
- Cancer Research 186
Countries citing papers authored by Pengpeng Xu
This map shows the geographic impact of Pengpeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengpeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengpeng Xu more than expected).
Fields of papers citing papers by Pengpeng Xu
This network shows the impact of papers produced by Pengpeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengpeng Xu. The network helps show where Pengpeng Xu may publish in the future.
Co-authorship network of co-authors of Pengpeng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Pengpeng Xu. A scholar is included among the top collaborators of Pengpeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengpeng Xu. Pengpeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 18 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 46 | |
| 11 | 6 | |
| 12 | 6 | |
| 13 | 11 | |
| 14 | 24 | |
| 15 | 30 | |
| 16 | 9 | |
| 17 | 7 | |
| 18 | 1 | |
| 19 | 6 | |
| 20 | 2 |
About Pengpeng Xu
Pengpeng Xu is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 83 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (47 papers), CAR-T cell therapy research (21 papers) and Chronic Lymphocytic Leukemia Research (14 papers). The work is most often cited by research in Pathology and Forensic Medicine (387 citations), Oncology (396 citations) and Cancer Research (186 citations). Pengpeng Xu has collaborated with scholars based in China, France and United States. Frequent co-authors include Shu Cheng, Weili Zhao, Li Wang, Di Fu, Li Wang, Jinyan Huang, Ying Fang, Hongmei Yi, Mengyuan Ji and Yao‐Hui Huang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.